Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Published:2020-09 Issue:9 Volume:21 Page:1224-1233
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Baize Nathalie,Monnet Isabelle,Greillier Laurent,Geier Margaux,Lena Hervé,Janicot Henri,Vergnenegre Alain,Crequit Jacky,Lamy Regine,Auliac Jean-Bernard,Letreut Jacques,Le Caer Hervé,Gervais Radj,Dansin Eric,Madroszyk Anne,Renault Patrick-Aldo,Le Garff Gwenaëlle,Falchero Lionel,Berard Henri,Schott Roland,Saulnier Patrick,Chouaid Christos

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Management of small-cell cancer of the lung;Hansen;Lancet,1992

2. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up;Sundstrøm;J Clin Oncol,2002

3. Etoposide plus cisplatin with or without the combination of 4-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study;Pujol;J Natl Cancer Inst,2001

4. Reinduction chemotherapy in small cell lung cancer;Giaccone;Eur J Cancer Clin Oncol,1987

5. Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer;Wakuda;Am J Clin Oncol,2015

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camptothecin multifunctional nanoparticles effectively achieve a balance between the efficacy of breast cancer treatment and the preservation of intestinal homeostasis;Bioactive Materials;2024-11

2. Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer;Respiratory Medicine and Research;2024-11

3. Aktuelle Standards und vielversprechende Innovationen in der medikamentösen Zweitlinientherapie des metastasierten kleinzelligen Lungenkarzinoms (ED-SCLC);Die Onkologie;2024-08-02

4. Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study;Lung Cancer;2024-08

5. Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer;Frontiers in Oncology;2024-07-31